LYDIA ACEVEDO: Open Payments
NPI 1831805654 · MOUNT LAUREL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 47 payments from 14 companies in 2025. Trend: 2023 $327 · 2024 $613 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $205 |
| ABBVIE INC. | 9 | $188 |
| Ardelyx, Inc. | 6 | $184 |
| GENZYME CORPORATION | 3 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Philips North America LLC | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| Janssen Biotech, Inc. | 2 | $37 |
| Novo Nordisk Inc | 1 | $35 |
| Madrigal Pharmaceuticals | 1 | $27 |
Products named: XIFAXAN, DUPIXENT, IBSRELA, MAVYRET, ENTYVIO, TREMFYA, MCOT, Wegovy.
Industry payments across NJ — which companies pay providers there.
